File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing

TitleDirect Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing
Authors
Issue Date2015
Citation
Clinical Cancer Research, 2015, v. 21 n. 15, p. 3442-3452 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/212511
ISSN
2023 Impact Factor: 10.0
2023 SCImago Journal Rankings: 4.623
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJia, J-
dc.contributor.authorDellinger, A-
dc.contributor.authorWeiss, E-
dc.contributor.authorBulusu, A-
dc.contributor.authorRushing, C-
dc.contributor.authorLi, H-
dc.contributor.authorHoward, L-
dc.contributor.authorKaplan, N-
dc.contributor.authorPang, HMH-
dc.contributor.authorHurwitz, H-
dc.date.accessioned2015-07-21T02:38:11Z-
dc.date.available2015-07-21T02:38:11Z-
dc.date.issued2015-
dc.identifier.citationClinical Cancer Research, 2015, v. 21 n. 15, p. 3442-3452-
dc.identifier.issn1078-0432-
dc.identifier.urihttp://hdl.handle.net/10722/212511-
dc.languageeng-
dc.relation.ispartofClinical Cancer Research-
dc.titleDirect Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing-
dc.typeArticle-
dc.identifier.emailPang, HMH: herbpang@hku.hk-
dc.identifier.authorityPang, HMH=rp01857-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1158/1078-0432.CCR-14-2819-
dc.identifier.pmid25878330-
dc.identifier.pmcidPMC4772720-
dc.identifier.scopuseid_2-s2.0-84942847070-
dc.identifier.hkuros244618-
dc.identifier.volume21-
dc.identifier.issue15-
dc.identifier.spage3442-
dc.identifier.epage3452-
dc.identifier.isiWOS:000361907800013-
dc.identifier.issnl1078-0432-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats